Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Peter Schwartz is a partner in our New York office and the chair of our finance practice. He represents lenders and borrowers in leveraged finance transactions, and also has extensive experience in private equity and M&A.

Mr. Schwartz is the principal counsel for a number of private debt funds, private investment funds, private equity firms and their portfolio companies, and public and private companies. He represents them in direct, club and syndicated financing transactions, many of which involve cross-border components. Mr. Schwartz's experience covers a wide range of financial products, including senior secured and unitranche loans, second lien financings, mezzanine debt, subordinated notes, preferred stock, warrants, and structured financings. He also represents purchasers and sellers in the monetization of pharmaceutical royalty streams (structured both as sales and financings).

  • Private investment funds focused on growth, acquisition and special situation financings for pharmaceutical, biotechnology, medical device and healthcare companies in numerous secured debt, royalty and equity financings, ranging in value from $20 million to $300 million.
  • Private debt funds focused on growth, acquisition, and special situation financing in numerous secured debt and equity financings for companies and private equity firms in various industries, ranging in value from $30 million to $300 million. 
  • Private equity funds in senior secured and mezzanine financings for a number of their acquisitions and portfolio companies, ranging in value from $25 million to $500 million.
  • Fortune 500 companies in their auction and sale of royalty streams on prescription and OTC pharmaceutical products.
  • A Fortune 500 company in its global debt financings, including first, second and third lien financings, secured and unsecured high yield bonds, and credit facilities in Europe, Asia and Latin America, ranging in value from $200 million to $3.3 billion.
  • Private equity funds in numerous leveraged buyouts of companies in industries including life sciences, education, food service, healthcare services, automotive, branded goods, telecom, and financial services, ranging in value from $40 million to $350 million.
  • A venture-backed corporation in a number of secured financings, ranging in value from $25 million to $75 million.
  • A leading hedge fund in the acquisition of a mortgage origination and servicing business.
  • A major international consumer goods company in the sales of a number of non-core businesses.
  • A major international life sciences company in a number of public and private acquisitions.
  • BTI Client Service All-Star, Finance (2015)
  • Legal 500 US, M&A - National Firms - Large Deals (2009)
  • Legal 500 US, Private Equity Buyouts - Middle Market (2008)